Results 201 to 210 of about 112,750 (251)

Angiotensin converting enzyme and angiotensin converting enzyme inhibitors in dermatology: a narrative review

Expert Review of Clinical Pharmacology, 2022
Angiotensin converting enzyme inhibitors (ACEI) are commonly used for cardiovascular diseases. The evidence supporting the use of ACEI in dermatology is limited.This review article was divided into three parts. The first part discusses ACEI in clinical use in dermatology.
Yang Lo
exaly   +3 more sources

Angiotensin-Converting Enzyme Inhibitors

Medical Clinics of North America, 1988
There is convincing evidence that ACE inhibitors, alone or in combination with a diuretic, effectively lower blood pressure in patients with all grades of essential or renovascular hypertension and that they are of particular benefit as adjunctive therapy in patients with congestive heart failure.
H H, Rotmensch, P H, Vlasses, R K, Ferguson   +2 more
  +7 more sources

Angiotensin-Converting Enzyme Inhibitors

Journal of Hypertension, 1991
The introduction of angiotensin-converting enzyme (ACE) inhibitors for the treatment of hypertension and heart failure is probably the most important advance in cardiovascular pharmacotherapy in the last few decades. Although the role of the renin-angiotensin system (RAS) in cardiovascular diseases had been investigated extensively for more than 70 yr,
Irene Gavras, Haralambos Gavras
openaire   +4 more sources

Angiotensin Converting Enzyme Inhibitors

American Journal of Hypertension, 1990
This review focuses on the use of angiotensin converting enzyme (ACE) inhibitors in hypertensive diseases. Specifically discussed are: proposed mechanisms of action, the pharmacology of the commercially available ACE inhibitors (captopril, enalapril, and lisinopril), their renal effects, and their safety and efficacy.
B L, Herlihy, J T, Herlihy
openaire   +4 more sources

Angiotensin-Converting Enzyme Inhibitor Angioedema

Advanced Emergency Nursing Journal, 2020
Angioedema from angiotensin-converting enzyme inhibitors (ACEIs) is a potential, emergent, and frightening problem that presents to the emergency department. This article focuses on angioedema caused by using ACEIs. The presentation, pathology, diagnostic testing, treatment, and patient education of angioedema are explored.
Josh, Bankston, David Thomas, House
openaire   +4 more sources

Angiotensin-converting enzyme inhibitors in the elderly

American Heart Journal, 1989
Although early studies suggested little role for angiotensin-converting enzyme (ACE) inhibitors in older hypertensive patients, more careful evaluation has confirmed their efficacy and good tolerability. Although the elderly tend to have low plasma renin levels, the fall in blood pressure after ACE inhibitors is at least as great (and in several ...
J L, Reid, N J, Macdonald, K R, Lees, H L, Elliott   +3 more
openaire   +2 more sources

Angiotensin-converting enzyme inhibitors

2001
Publisher Summary Angiotensin-converting enzyme (ACE) inhibitors were first studied clinically in the 1970s. ACE inhibitors were discovered by taking advantage of previous basic research on the physiology of sodium, potassium, and water homeostasis and blood pressure regulation, in a reciprocal way ACE have also advanced research in this field, and ...
J, Menard, A A, Patchett
openaire   +3 more sources

Angiotensin converting enzyme inhibitors

Pharmaceutisch Weekblad Scientific Edition, 1982
Inhibition of angiotensin converting enzyme (ACE) in patients suffering from renovascular hypertension results in lowering of the blood-pressure. The development of captopril, an orally active ACE inhibitor and the structure-activity relationship of captopril analogues are described.
openaire   +2 more sources

Angiotensin-Converting Enzyme Inhibitors

Medical Clinics of North America, 1987
In summary, ACE inhibitors are effective in reducing blood pressure as initial therapy in some hypertensive patients and in combination with diuretics and other agents in virtually all hypertensives. ACE inhibitors are uniquely advantageous because of their favorable hemodynamic effects, the lack of adverse metabolic effects, and their ability to ...
openaire   +2 more sources

Angiotensin-converting enzyme inhibitors

Medicine of Ukraine, 2022
The article reflects the issues of pharmacology and pharmacokinetics of the use of drugs belonging to the group of angiotensin – converting enzyme inhibitors. Given the high risks to the life of children and adults, the clinician must have knowledge of the classification, mechanism of action and possible side effects of this group of drugs.
I. M. Yachnyk, N. P. Karpenko, O. V. Kushneryk, N. M. Tarasenko   +3 more
openaire   +1 more source